Sentences with phrase «arterial hypertension drugs»

Not exact matches

Johnson & Johnson has been jockeying to snap up Actelion, Europe's largest biotech and a maker of drugs for the deadly heart and lung condition pulmonary arterial hypertension (PAH).
One of the year's biggest biopharma M&A scuffles came to an end in January when Johnson & Johnson finally struck a deal to buy Actelion, Europe's biggest biotech and a maker of pulmonary arterial hypertension (PAH) drugs.
The company's lead candidate is Trevyent, a development stage drug product that utilizes SteadyMed's PatchPump technology to administer treprostinil, a vasodilatory prostacyclin analogue to treat pulmonary arterial hypertension.
United Therapeutics will pay $ 4.46 per share in cash at closing yesterday and an additional $ 2.63 per share in cash upon the achievement of a milestone related to the commercialization of SteadyMed's leading drug candidate Trevyent for the treatment of Pulmonary Arterial Hypertension (PAH).
Both SteadyMed and United Therapeutics have anchored their portfolios with drugs that treat pulmonary arterial hypertension.
Metoprolol, a drug of the beta - blocker family, has been available for more than 30 years to treat arterial hypertension and other cardiovascular conditions.
Edward Bullmore, UK Robert Dow, UK Garrett Fitzgerald, USA - Prostanoid biology and the role of peripheral molecular clocks in cardiovascular biology, metabolism and aging Alex Phipps, UK - Oncology, Clinical Pharmacology, Biologics and Immunotherapy Patrick du Souich, Canada - Cytochrome P450, membrane carriers, disease, inflammation, rational use of drugs, clinical pharmacology David J. Webb, UK - hypertension, chronic kidney disease, endothelial function and dysfunction, arterial stiffness, health technology assessment, medicines regulation Don Birkett, Australia - Clinical pharmacology / pharmacokinetics and drug utilisation
a b c d e f g h i j k l m n o p q r s t u v w x y z